Sort
51,593 grants matching “hepatitis”
Expanding Medication Assisted Therapy in Ukraine (ExMAT)
$658,981Frederick Lewis Altice · Yale University · R01 · FY2020 · DA
Core C: Cardiovascular Pathology Core
$658,978Timothy E O'Toole · American Heart Association · P50 · FY2013 · HL
WOMEN DRUG USERS, THEIR MALE PARTNERS AND HIV RISK
$658,941National Development &Res Institutes · R01 · FY2002 · DA
Development of a topical malaria vaccine.
$658,790Elizabeth H Nardin · New York University School Of Medicine · R01 · FY2017 · AI
Integrated Stepped Care for Unhealthy Alcohol Use in HIV
$658,783David Fiellin · Yale University · U01 · FY2011 · AA
Peripheral Reservoir of HIV DNA in Monocytes Pivotal to Cognition in HIV
$658,773Victor Valcour · University Of California, San Francisco · R01 · FY2009 · NS
NOVEL STRATEGIES TO IMPROVE LIVER CANCER SURVEILLANCE UPTAKE AND EARLY DETECTION
$658,591Anna Sf Lok · University Of Michigan At Ann Arbor · U01 · FY2019 · CA
Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics
$658,576Joanne E Curran · University Of Texas Rio Grande Valley · U54 · FY2024 · HG
The function and regulation of the novel pregnancy-specific hexokinase HKDC1
$658,483Brian Thomas Layden · University Of Illinois At Chicago · R01 · FY2022 · DK
Assessing the Reach, Effectiveness, and Implementation of Multiple Interventions
$658,368Alexander H Kral · Research Triangle Institute · R01 · FY2025 · DA
Role of the Gut Microbiota in Abdominal Aortic Aneurysm
$658,280Albert Phillip Owens III · University Of Cincinnati · R01 · FY2020 · HL
Health Services Research: Extended Release Naltrexone for Opioid-Dependent Youth
$658,191Shannon Gwin Mitchell · Friends Research Institute, Inc. · R01 · FY2016 · DA
Accelerating novel countermeasures against RNA viruses through repurposing
$658,172Shirit Einav · Stanford University · U19 · FY2016 · AI
Metabolic Actions of FGF21
$658,162Eleftheria Maratos-Flier · Beth Israel Deaconess Medical Center · R01 · FY2017 · DK
Metabolic Actions of FGF21
$658,162Eleftheria Maratos-Flier · Beth Israel Deaconess Medical Center · R01 · FY2016 · DK
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
$658,058Jagpreet Chhatwal · Massachusetts General Hospital · · FY2017 · CSE
Interactions between neutrophils and cholangiocytes in alcoholic hepatitis
$658,046Michael H Nathanson · Yale University · R01 · FY2022 · AA
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERS
$658,044Johns Hopkins University · R01 · FY2001 · DA
Community-based Self-management of HIV and Chronic Disease
$658,003Sheryl L Catz · Kaiser Foundation Health Plan Of Washington · R01 · FY2010 · MH
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2025 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2024 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2021 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2022 · GM
URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)
$658,000Richard Saitz · Boston University Medical Campus · U01 · FY2016 · AA
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2023 · GM